Natco Pharma Of India Buys U.S.-Based Newark Drugs
This article was originally published in PharmAsia News
India's Natco Pharma says it has bought the assets of Newark Drugs drugstore chain in the U.S. The purchase price was not announced, but Newark Drugs has about $5 million in annual sales. The acquisition, which was made through the K&C Pharmacy general partnership in which Natco has 75 percent ownership, would be the India company's third since 2006. Natco's other property buys were Nicks' Drugs and SaveMart Drugs. (Click here for more
You may also be interested in...
Results of three-year study conducted at 17 Canadian sites suggest that e-cigarettes use combined with counseling significantly increased abstinence from smoking cigarettes compared to receiving counseling alone.
Cambridge Nutraceuticals - which develops dietary supplements that have “proven clinical benefits” - has snapped up UK-based Prime Fifty to enhance its offering with products specifically designed for the over 50s.
Shanghai Henlius Biotech has begun dosing in a Phase I trial for its HLX14 planned biosimilar version of denosumab. Multiple biosimilar developers are vying to take a slice of the market for rivals to Amgen’s Xgeva/Prolia original.